Insulin‐like growth factor (IGF)‐I rescues breast cancer cells from chemotherapy‐induced cell death – proliferative and anti‐apoptotic effects Jennifer L. GoochCarla L. Van Den BergDouglas Yee OriginalPaper Pages: 1 - 10
Suppression of parathyroid hormone‐related protein messenger RNA expression by medroxyprogesterone acetate in breast cancer tissues Takuji SugimotoEiichi ShibaShin‐ichiro Takai OriginalPaper Pages: 11 - 23
Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer Mitchell DowsettDebbie DoodyR Charles Coombes OriginalPaper Pages: 25 - 34
Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas Douglas E. LauxEdward M. CurranTim H.‐M. Huang OriginalPaper Pages: 35 - 43
Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery Kojiro ShimozumaPatricia A. GanzKarim Hirji OriginalPaper Pages: 45 - 57
Rural breast cancer treatment: evidence from the Reaching Communities for Cancer Care (REACH) project Sarah E. TropmanThomas C. RickettsTimothy Aldrich OriginalPaper Pages: 59 - 66
Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients Amelia InsaAna LluchJavier Garcia‐Conde OriginalPaper Pages: 67 - 78
Schedule‐dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro Yasuhiko KanoMiyuki AkutsuSaburo Tsunoda OriginalPaper Pages: 79 - 90
Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor‐1 in human breast cancer cell lines Dan TongKlaus CzerwenkaRobert Zeillinger OriginalPaper Pages: 91 - 97